Showing 611 articles
Glyn Hughes to Take the Reins of TIACA as Its First Director General
12 Nov 2020| Nola CadmanTIACA is The International Air Cargo Association, based in Miami, Florida. TIACA is the unique international not-for-profit association representing and uniting all parts of the air cargo industry
CatSci further strengthens its customer-focused Strategic Advisory Board with three key appointments
12 Nov 2020| Nola CadmanCatSci Ltd provides tailored process research and development services to emerging, mid-sized and large pharma. We proudly serve customers across the globe with projects, meeting their needs from IND-enabling through product launch.
ONK Therapeutics Opens US R&D Operations and Appoints Head of R&D, USA
12 Nov 2020| Mike WoodONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has been accepted to become a resident at Johnson & Johnson Innovation - JLABS @ San Diego. It is also pleased to announce that it has appointed Rohit Duggal Ph.D. to Head of R&D, USA, as its first employee based at its San Diego operations and has incorporated a US subsidiary, ONK Therapeutics, Inc.
Belgian biotech Apaxen appoints Bart Wuurman as CEO
12 Nov 2020| Mike WoodApaxen S.A., a privately-held preclinical stage biotechnology company, developing novel oral drugs for chronic inflammatory diseases, with a primary focus in pulmonary arterial hypertension (PAH), announced today that it has appointed Bart Wuurman (picture link) CEO.
PharmiWeb.Jobs Welcomes Marketplace Technical
10 Nov 2020| Nola CadmanMarketplace Technical in their own words...
-
Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective
9 Nov 2020| Nola CadmanPFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED SUCCESS IN FIRST INTERIM ANALYSIS FROM PHASE 3 STUDY
Brexit White Paper
5 Nov 2020The UK formally left the EU on 31st January 2020 and the transition period, as set out in the withdrawal agreement, will come to an end on 31st December 2020. During this transition period the UK has continued to remain under EU pharmaceutical law.
Amarna Therapeutics Appoints Kite Pharma veteran Dr. Markwin Velders to its Supervisory Board
4 Nov 2020| Nola CadmanExperienced biotech entrepreneur joins to support the company’s corporate development
Hearing Loss Company Acousia Therapeutics Strengthening its R&D Management Team
4 Nov 2020| Nola CadmanPrivately-held Acousia Therapeutics GmbH is based in Tübingen, Germany. The company is dedicated to the identification and development of small molecules for effective prevention and treatment of hearing loss. Acousia is developing drugs for local and systemic application.
Freeline appoints Mark Baldry as Chief Commercial Officer
4 Nov 2020| Nola CadmanFreeline is a clinical-stage biotechnology company focused on AAV-based gene therapy targeting the liver. Its vision is to create better lives for people suffering from chronic, systemic diseases using the potential of gene therapy as a one-time treatment to provide a potential functional cure. Freeline is headquartered in the UK and has operations in Germany and the US.
ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors
4 Nov 2020| Nola CadmanDevelopment of New Treatment Conferring Broad Protection Against Coronaviruses on Track
Polyplus-transfection Names Mario Philips As Chief Executive Officer
4 Nov 2020Appoints Dr. Andreas Rummelt and Jean-Paul Mangeolle to its Board of Directors
Top Pharma Companies Hiring In November, 2020
4 Nov 2020| Nola CadmanTop Pharma Companies Hiring In November 2020
Top Pharma Recruiters Advertising in November , 2020
4 Nov 2020| Nola CadmanHere's a list of the top pharma and life science recruitment companies advertising in November on PharmiWeb.jobs
PharmiWeb.Jobs Welcome Grovelands
30 Oct 2020| Nola CadmanGrovelands is a challenger Consultancy and Resource provider working in the Life Sciences and Financial Services sectors.
CGT Catapult appoints two new Board members
29 Oct 2020| Nola CadmanThe Cell and Gene Therapy (CGT) Catapult today announces the appointment of Professor Angela Thomas OBE and Christine Soden as non-executive Directors to its Board. The new appointments will join current Board members in supporting the activities of the Cell and Gene Therapy Catapult.
Oculis appoints David Jacobs, M.D. as Chief Development Officer adding complementary drug development and regulatory expertise
29 Oct 2020| Nola CadmanOculis S.A., a biopharmaceutical company focused on developing transformative topical ophthalmic treatments to improve the sight and lives of patients, announces the appointment of David Jacobs, M.D., as Chief Development Officer. Dr. Jacobs will be based in Oculis’ newly established U.S. office.
UNION therapeutics appoints Dr. Kim Kjoeller as Chief Executive Officer and further strengthens leadership by appointing Dr. Günter Ditzinger as Chief Technology Officer
29 Oct 2020| Nola CadmanUNION therapeutics A/S (“UNION”), a privately held clinical stage pharmaceutical company focusing on infectious and inflammatory diseases, announced further strengthening of the leadership team.
Clinical Professionals, RIG Healthcare and Cpl Specialist Talent join forces to form to Cpl UK.
28 Oct 2020| Nola CadmanCpl is a global provider of talent solutions to startup companies, multinationals and SMEs in every sector from Pharmaceuticals to Fund Accounting. Founded in 1989, the Cpl Group now comprises 23 brands spanning more than 41 offices in 11 countries. Matching the right talent to the right organisation is the core guiding principle in everything we do.
Company Career Hubs
27 Oct 2020| Nola CadmanVisit one of the Company Career hubs to find out more about what it is like to work at the organisation, the company ethos, and other valuable career information.
